Enlightenment Research’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,800
Closed -$758K 50
2022
Q3
$758K Buy
+8,800
New +$786K 1.68% 15
2022
Q1
Sell
-8,300
Closed -$636K 177
2021
Q4
$636K Buy
+8,300
New +$661K 0.9% 34
2021
Q2
Sell
-4,716
Closed -$347K 189
2021
Q1
$347K Buy
+4,716
New +$348K 0.42% 68
2020
Q3
Sell
-3,144
Closed -$232K 104
2020
Q2
$232K Sell
3,144
-3,039
-49% -$229K 0.55% 55
2020
Q1
$452K Buy
+6,183
New +$486K 0.48% 50
2019
Q4
Sell
-5,554
Closed -$446K 101
2019
Q3
$446K Sell
5,554
-4,192
-43% -$336K 0.99% 34
2019
Q2
$737K Sell
9,746
-878
-8% -$67.2K 0.38% 74
2019
Q1
$843K Buy
10,624
+9,201
+647% +$688K 1.64% 17
2018
Q4
$104K Buy
+1,423
New +$100K 0.13% 171

Other funds holding MRK

Enlightenment Research's MRK Position: Q4 2022 in Review

Enlightenment Research sold out of Merck (MRK) in Q4 2022, closing a stake of 8,800 shares — an estimated $758K sold.

Enlightenment Research first reported a position in MRK in Q4 2018 and held it in 9 quarters. The position peaked at $843K in Q1 2019. 3,235 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Enlightenment Research reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Enlightenment Research sold 8,800 Merck shares in Q4 2022, an estimated $758K.
  • Enlightenment Research first reported a position in Merck in Q4 2018 and held it in 9 quarters.
  • Enlightenment Research's Merck position peaked at $843K in Q1 2019.
  • 3,235 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Enlightenment Research's 13F filing for Q4 2022.